OKYO Pharma OKYO
NASDAQ OKYO
$1.47 +0.15 (+11.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Other Non Operating Income (2025 - 2026)

Updated

OKYO Pharma's Other Non Operating Income was -$603,772 in the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Other Non Operating Income (2025 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, Other Non Operating Income at OKYO Pharma came in at -$700,750.

  • In earlier years, Other Non Operating Income was -$96,978 in the year ended Mar 31, 2025, $55,183 in the year ended Dec 31, 2024 (+7.8%), $51,192 in the year ended Dec 31, 2023 and -$12.62 billion in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 OKYO Pharma 901.51 Mn 901.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -603,772.00
Dec 31, 2025 194,292.00
API Access

OKYO Pharma Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=OKYO&period=max&api_key=YOUR_API_KEY